MEDIOCON INC – Leminoprazole is a benzimidazole-derived acid pump inhibitor that acts on the gastric H⁺/K⁺-ATPase system. It has been investigated for its ability to inhibit gastric acid secretion and is structurally related to proton pump inhibitor compounds.
Leminoprazole, also known as NC-1300-O-3, is a small-molecule benzimidazole derivative. It inhibits the gastric H⁺/K⁺-ATPase proton pump and has been investigated for effects on gastric acid secretion and gastric mucosal protection. Published research describes Leminoprazole as an orally active acid-pump inhibitor.
Product Name: Leminoprazole
CAS Number: 104340-86-5
Molecular Formula: C₁₉H₂₃N₃OS
Molecular Weight: Approximately 341.47 g/mol
Chemical Class: Benzimidazole derivative
Synonyms: NC-1300-O-3, Leminoprazol
IUPAC Name: 2-(1H-benzimidazol-2-ylsulfinylmethyl)-N-methyl-N-(2-methylpropyl)aniline
PubChem CID: 65881
Leminoprazole inhibits the gastric proton pump H⁺/K⁺-ATPase. Research has reported inhibition of gastric acid secretion and effects on gastric mucus synthesis. The compound has been investigated in experimental models for its acid-suppressing and gastric-protective properties.
MEDIOCON INC focuses on supplying pharmaceutical and specialty ingredients with emphasis on quality, consistency, technical documentation and reliable supply.
Leminoprazole quality evaluation may include identity, assay, chromatographic purity, related substances, residual solvents, water content, residue on ignition and other parameters according to the applicable product specification and intended application.
The exact analytical acceptance criteria should be confirmed against the current approved specification and batch-specific Certificate of Analysis.
Leminoprazole has been investigated as a gastric acid secretion inhibitor and H⁺/K⁺-ATPase inhibitor. Research has evaluated its effects on gastric acid secretion and gastric mucosal factors. Its regulatory status and permitted application should be confirmed for the intended market and use.
Leminoprazole is a defined small-molecule organic compound with the molecular formula C₁₉H₂₃N₃OS and molecular weight of approximately 341.47 g/mol. Available chemical references identify CAS 104340-86-5 and PubChem CID 65881.
Product availability, packaging configuration, Certificate of Analysis (COA), Safety Data Sheet (SDS/MSDS), technical specifications and other documentation should be confirmed with MEDIOCON INC according to the intended application and customer requirements.
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Leminoprazole API Manufacturer and Supplier in India (CAS 104340-86-5) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Leminoprazole API Manufacturer and Supplier in India is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.
Export Markets
Quality & Compliance